Radzikowska, Urszula http://orcid.org/0000-0002-7341-9764
Eljaszewicz, Andrzej http://orcid.org/0000-0002-8980-1474
Tan, Ge http://orcid.org/0000-0003-0026-8739
Stocker, Nino
Heider, Anja http://orcid.org/0000-0002-3448-4125
Westermann, Patrick http://orcid.org/0000-0003-2894-6140
Steiner, Silvio http://orcid.org/0000-0003-1999-1425
Dreher, Anita
Wawrzyniak, Paulina
Rückert, Beate http://orcid.org/0000-0003-1804-1698
Rodriguez-Coira, Juan
Zhakparov, Damir
Huang, Mengting
Jakiela, Bogdan http://orcid.org/0000-0003-0444-981X
Sanak, Marek http://orcid.org/0000-0001-7635-8103
Moniuszko, Marcin http://orcid.org/0000-0001-7183-3120
O’Mahony, Liam http://orcid.org/0000-0003-4705-3583
Jutel, Marek
Kebadze, Tatiana
Jackson, David J.
Edwards, Michael R.
Thiel, Volker http://orcid.org/0000-0002-5783-0887
Johnston, Sebastian L. http://orcid.org/0000-0003-3009-9200
Akdis, Cezmi A. http://orcid.org/0000-0001-8020-019X
Sokolowska, Milena http://orcid.org/0000-0001-9710-6685
Article History
Received: 11 February 2022
Accepted: 16 March 2023
First Online: 22 April 2023
Change Date: 13 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-39275-x
Competing interests
: CA reports research grants from Allergopharma, Idorsia, Swiss National Science Foundation, Christine Kühne-Center for Allergy Research and Education, European Commission’s Horison’s 2020 Framework Programme “Cure”, Novartis Research Institutes, Astrazeneca, SciBase, Stanford University SEAN Parker Asthma and Allergy Center; advisory board of Sanofi/Regeneron, GSK and Novartis, consulting fees from Novartis; Editor-in-Chief Allergy, Co-Chair EAACI Environmental Science in Allergic Diseases and Asthma Guidelines. AE reports National Science Centre Grant No. 2020/37/N/NZ5/04144, National Centre for Research and Development No. STRATEGMED2/269807/14/NCBR/2015, National Centre for Research and Development (POLTUR3/MT-REMOD/2/2019). DJJ reports advisory board and speaker fees from AstraZeneca, GSK and Sanofi and research grants from AstraZeneca. SLJ reports grants/contracts from European Research Council ERC FP7 grant number 233015, Chair from Asthma UK CH11SJ, Medical Research Council Centre grant number G1000758, NIHR Biomedical Research Centre grant number P26095, Predicta FP7 Collaborative Project grant number 260895, NIHR Emeritus NIHR Senior Investigator; consulting fees from Lallemand Pharma, Bioforce, resTORbio, Gerson Lehrman Group, Boehringer Ingelheim, Novartis, Bayer, Myelo Therapeutics GmbH; patents issued/licensed: Wark PA, Johnston SL, Holgate ST, Davies DE. Anti-virus therapy for respiratory diseases. UK patent application No. GB 0405634.7, 12March 2004. Wark PA, Johnston SL, Holgate ST, Davies DE. Interferon-Beta for Anti-Virus Therapy for Respiratory Diseases. International Patent Application No. PCT/GB05/50031, 12 March 2004. Davies DE, Wark PA, Holgate ST, JohnstonSL. Interferon Lambda therapy for the treatment of respiratory disease. UK patent application No. 6779645.9, granted15th August 2012; Participation on a data safety monitory board or advisory board: Enanta Chair of DSMB, Virtus Respiratory Research Board membership. MJ reports RID- European Commission Research Grant, personal fees from Allergopharma, Stallergenes, Regeneron, Pfizer, Chiesi, Allergopharma, Stallergenes Greer, HAL Allergy; membership in safety monitoring board in Allergopharma; EAACI President position; Clinical Investigator Honoraria from GSK, AstraZeneca, Regeneron, Genetech, Takeda, Chiesi, Novartis, Allergopharma, Stallergenes, Allergy Therapeutics, HAL Allergy, ALK Abello, Shire, Celltrion, Verona Pharma. MM reports personal payments from Astra Zeneca, GSK, Berlin-Chemie/Menarini, Lek-AM, Takeda, Celon and support for attending meetings from Astra Zeneca, GSK, Berlin-Biochemie/Menarini. UR reports board secretary position of Working Group of Genomics and Proteomics of the European Academy of Allergy and Clinical Immunology (EAACI). JRC reports Pre-doctoral grant FPI from Universidad CEU San Pablo, Swiss European Mobility Program grant from University of Zurich, EAACI Mid-term Fellowship. M.So reports research grants from Swiss National Science Foundation (nr 310030_189334/1), Novartis Foundation for Medical-Biological Research, GSK, and Stiftung vorm. Buendner Heilstaette Arosa; speaker’s fee from AstraZeneca; voluntary positions in the European Academy of Allergy and Clinical Immunology (EAACI) as Executive Board member and Basic and Clinical Immunology Section Chair. SS reports funding from National Center of Competence in Research (NCCR) on RNA and Disease to VT (ExternalRef removed). VT reports grant from Swiss National Science Foundation (nr 31CA30_196644). All other authors declare no competing interest.